17-ketosteroids and Nervous-System-Diseases

17-ketosteroids has been researched along with Nervous-System-Diseases* in 5 studies

Reviews

1 review(s) available for 17-ketosteroids and Nervous-System-Diseases

Article	Year
[Review of the literature of the pathogenesis of chronic carbon disulfide intoxication]. Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete, 1967, Volume: 13, Issue:10 Topics: 17-Ketosteroids; Air Pollution; Carbon Disulfide; Chronic Disease; Fibrinolysis; Humans; Kidney Diseases; Lipid Metabolism; Liver Diseases; Nervous System Diseases; Vascular Diseases	1967

Trials

1 trial(s) available for 17-ketosteroids and Nervous-System-Diseases

Article	Year
[Equilin sulphate in the treatment of the menopausal syndrome (author's transl)]. Wiener klinische Wochenschrift, 1975, Jan-24, Volume: 87, Issue:2 0.25 sodium equilin sulphate and 0.625 mg Premarin were compared as to their effects in 12 postmenopausal syndrome. The initial daily dosage of 0.25 mg equilin had a stronger oestrongenic effect in the alleviation of vasomotor disturbances than subsequently-administered Premarin. No significant difference was found in effect on the vaginal epithelium or the endometrium or in the incidence of irregular bleeding. The number of women in whom withdrawal bleeding was reported was considerably reduced by lowering the dosage to 0.2 mg equilin sulphate. Consequently 0.2 to 0.3 mg equilin sulphate must be considered the optimum dosage. Topics: 17-Ketosteroids; Autonomic Nervous System; Climacteric; Clinical Trials as Topic; Drug Evaluation; Equilin; Female; Humans; Menopause; Middle Aged; Nervous System Diseases; Ovary; Postoperative Complications; Sleep Wake Disorders; Syndrome; Time Factors	1975

Article

Year

[Equilin sulphate in the treatment of the menopausal syndrome (author's transl)].

Wiener klinische Wochenschrift, 1975, Jan-24, Volume: 87, Issue:2

0.25 sodium equilin sulphate and 0.625 mg Premarin were compared as to their effects in 12 postmenopausal syndrome. The initial daily dosage of 0.25 mg equilin had a stronger oestrongenic effect in the alleviation of vasomotor disturbances than subsequently-administered Premarin. No significant difference was found in effect on the vaginal epithelium or the endometrium or in the incidence of irregular bleeding. The number of women in whom withdrawal bleeding was reported was considerably reduced by lowering the dosage to 0.2 mg equilin sulphate. Consequently 0.2 to 0.3 mg equilin sulphate must be considered the optimum dosage.

Topics: 17-Ketosteroids; Autonomic Nervous System; Climacteric; Clinical Trials as Topic; Drug Evaluation; Equilin; Female; Humans; Menopause; Middle Aged; Nervous System Diseases; Ovary; Postoperative Complications; Sleep Wake Disorders; Syndrome; Time Factors

1975

Other Studies

3 other study(ies) available for 17-ketosteroids and Nervous-System-Diseases

Article	Year
[Nervous system changes in the dumping syndrome]. Klinicheskaia meditsina, 1979, Volume: 57, Issue:9 Topics: 17-Ketosteroids; Brain; Catecholamines; Dumping Syndrome; Electroencephalography; Electrolytes; Glucose Tolerance Test; Humans; Hydroxycorticosteroids; Nervous System Diseases; Plethysmography, Impedance	1979
[Demonstration & significance of steroid hormones in the CSF]. Deutsche Zeitschrift fur Nervenheilkunde, 1958, Volume: 177, Issue:5 Topics: 17-Ketosteroids; Cerebrospinal Fluid; Humans; Nervous System Diseases; Steroids	1958
[Excretion of total 17 ketosteroids in certain mental and neurologic diseases]. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1951, Mar-31, Volume: 75, Issue:1 Topics: 17-Ketosteroids; Androgens; Body Fluids; Mental Disorders; Nervous System Diseases; Psychotic Disorders	1951